Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Operating Income Loss of $4.55 million for the year ending 2025.
- CHAMPIONS ONCOLOGY, INC. showed an increase of +161.9% in Operating Income Loss from 2024 to 2025.
- This data is from CHAMPIONS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on July 23, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: -$603.0 thousand | Q4 2010: -$1.02 million | Q1 2011: -$786.0 thousand | Q3 2011: -$2.21 million | Q4 2011: -$2.47 million | Q1 2012: -$1.77 million | Q3 2012: -$1.60 million | Q4 2012: -$1.92 million | Q1 2013: -$720.0 thousand | Q3 2013: -$766.0 thousand | Q4 2013: -$1.70 million | Q1 2014: -$1.41 million | Q3 2014: -$3.73 million | Q4 2014: -$3.67 million | Q1 2015: -$3.42 million | Q3 2015: -$2.90 million | Q4 2015: -$2.49 million | Q1 2016: -$2.37 million | Q3 2016: -$2.52 million | Q4 2016: -$493.0 thousand | Q1 2017: -$1.40 million | Q3 2017: -$619.0 thousand | Q4 2017: -$70.0 thousand | Q1 2018: -$67.0 thousand | Q3 2018: $481.0 thousand | Q4 2018: $275.0 thousand | Q1 2019: -$370.0 thousand | Q3 2019: -$614.0 thousand | Q4 2019: $291.0 thousand | Q1 2020: $433.0 thousand | Q3 2020: $24.0 thousand | Q4 2020: $7.0 thousand | Q1 2021: $982.0 thousand | Q3 2021: -$175.0 thousand | Q4 2021: $263.0 thousand | Q1 2022: $830.0 thousand | Q3 2022: -$284.0 thousand | Q4 2022: $7.0 thousand | Q1 2023: -$2.46 million | Q3 2023: -$2.55 million | Q4 2023: -$1.96 million | Q1 2024: -$2.58 million | Q3 2024: $1.33 million | Q4 2024: $732.0 thousand | Q1 2025: $4.50 million | Q3 2025: -$527.0 thousand | Q4 2025: $185.0 thousand | Q1 2026: -$276.0 thousand.
- Over the full 15 years of available data (2011 to 2025), CHAMPIONS ONCOLOGY, INC.'s Operating Income Loss has grown by 187.0%.
- Historical annual values: Fiscal year 2025: $4.55 million | Fiscal year 2024: -$7.36 million | Fiscal year 2023: -$5.26 million | Fiscal year 2022: $607.0 thousand | Fiscal year 2021: $366.0 thousand | Fiscal year 2020: -$1.92 million | Fiscal year 2019: $270.0 thousand | Fiscal year 2018: -$1.35 million | Fiscal year 2017: -$6.81 million | Fiscal year 2016: -$10.32 million | Fiscal year 2015: -$13.24 million | Fiscal year 2014: -$6.26 million | Fiscal year 2013: -$6.22 million | Fiscal year 2012: -$9.07 million | Fiscal year 2011: -$5.24 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: